Topical corticosteroids are recommended as first-line treatment for all levels of atopic dermatitis, as well as for ...

Nektar Therapeutics (NASDAQ:NKTR) shares climbed 3.6% on Monday after the biotech firm unveiled encouraging new data showing ...

Reviewed By Steven R. Feldman, MD, PhD, Professor of Dermatology, Pathology and Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina Coping with the symptoms ...

Habitual scratching is common among children and adults with AD, with the frequency of scratching increasing with greater disease severity.

Investing.com -- Nektar Therapeutics (NASDAQ:NKTR) stock rose 3.6% on Monday after the company presented new data showing its experimental drug rezpegaldesleukin improved asthma symptoms in patients ...

About 10 percent of people with atopic dermatitis, the most common type of eczema, have symptoms on their feet. Here are the most important things to know if you have it. Atopic dermatitis (the most ...

Atopic dermatitis (the most common type of eczema) causes dry, itchy skin with rough, scaly patches. It affects up to 30% of children and 10% of adults, with about 60% of cases starting before age 1.

Once-daily, effective, safe, and well-tolerated ZORYVE cream 0.05% now commercially available for children as young as age 2ZORYVE cream 0.05% ...

Experts discuss the unique challenges of managing atopic dermatitis (AD) in pediatric and adolescent patients, emphasizing the strategic use of topical treatments to improve adherence, reduce ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Experts discuss the importance of safe, effective topical therapies for long-term management of atopic dermatitis, ...

Please provide your email address to receive an email when new articles are posted on . Safety and tolerability were similar in both treatment groups. Roflumilast showed significant improvement across ...